Back to search
FDAFDA · Food and drugs·Recall number Z-0590-2024

Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED)

Published May 1, 2024 · Recall initiated: November 20, 2023

Summary

FDA records medical device Class II recall Z-0590-2024, published May 1, 2024 and initiated November 20, 2023. Recalling firm: LEICA BIOSYSTEMS NUSSLOCH GMBH; Status: Ongoing; Reported quantity: 98 devices; Lot: All devices with serial number: G0061-G0701. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or edited protocols.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
LEICA BIOSYSTEMS NUSSLOCH GMBH
Distributor
US, Nationwide
Lot
All devices with serial number: G0061-G0701
Risk classification
Class II
Area (FDA)
device
Country
Germany

Related recalls

Questions about this recall

Was Leica HistoCore PEGASUS (PROCESSOR, TISSUE, AUTOMATED) recalled?

Yes. FDA published recall Z-0590-2024 on May 1, 2024. Reported hazard: There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore PEGASUS Plus resulting from an incorrect assignment of the carryover value set for created or edited protocols.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail